DXC-003

N/A

Report date: 2025/02/13 16:05:21

Base Information

Drug NameDXC-003
Drug Alias NameDAC-003DXC-003
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Tub201 payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionTumor-associated calcium signal transducer 2 inhibitors
TargetsTumor-associated calcium signal transducer 2
Therapy Area/IndicationsSmall Cell Lung CarcinomaTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Dac Biotech Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Dac Biotech Company Ltd
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A